Interactions between TNF and GnRH

Tumour necrosis factor (TNF) ligand members and their associated TNF receptor (TNFR) superfamilies have many diverse physiological roles. TNF is thought to play a critical role in the pathophysiology of a range of diseases including refractory asthma, sepsis, ankylosing spondylitis, lupus, type II diabetes, multiple sclerosis and psoriasis. The recent continued expansion of the novel anti-TNF therapeutic agents (etanercept and infliximab) has seen major improvements in the treatment of some inflammatory-based human diseases including notably rheumatoid arthritis and Crohn’s disease, with other conditions currently being trialled using anti-TNF agents. The cellular signalling machinery used by TNFRs to achieve their many cellular responses are discussed, as is the gonadotrophin-releasing hormone (GnRH) receptor signalling mechanisms. TNF is known to have many actions throughout the body including effects on the hypothalamic-pituitary-adrenal/gonadal axes, with many anti-gonadotrophic effects including a role in the development of endometriosis. These interactions between TNF, GnRH and gonadotrophs are discussed. Similar content being viewed by others

Beutler B, Greenwald D, Hulmes JD et al (1985) Identity of tumor necrosis factor and the macrophage-secreted factor cachectin. Nature 316:552–554 Loetscher H, Gentz R, Zulauf M et al (1991) Recombinant 55-KDa tumor-necrosis-factor (TNF) receptor—stoichiometry of binding to TNF-α and TNF-β and inhibition of TNF activity. J Biol Chem 266:18324–18329 Fiers W, Beyaert R, Boone E et al (1996) TNF-induced intracellular signaling leading to gene induction or to cytotoxicity by necrosis or by apoptosis. J Inflamm 47:67–75 Aggarwal BB, Shishodia S, Takada Y et al (2006) TNF blockade: an inflammatory issue. Ernst Schering Res Found Workshop 56:161–186 Rothwell NJ (1988) Central effects of TNF alpha on thermogenesis and fever in the rat. Biosci Rep 8:345–352 Gaillard RC, Turnill D, Sappino P et al (1990) Tumor necrosis factor α inhibits the hormonal response of the pituitary gland to hypothalamic releasing factors. Endocrinol 127:101–106 Cerami A, Beutler B (1988) The role of cachectin/TNF in endotoxic-shock and cachexia. Immunol Today 9:28–31 Spriggs DR, Sherman ML, Frei E et al (1987) Clinical studies with tumour necrosis factor. Ciba Found Symp 131:206–227 Arend WP (2002) The mode of action of cytokine inhibitors. J Rheumatol 65:16–21 McDevitt H, Munson S, Ettinger R et al (2002) Multiple roles for tumor necrosis factor-α and lymphotoxin α/β in immunity and autoimmunity. Arthritis Res 4:S141–S152 Pennica D, Nedwin GE, Hayflick JS et al (1984) Human-tumor necrosis factor—precursor structure, expression and homology to lymphotoxin. Nature 312:724–729 Ashkenazi A (2002) Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nature Rev Cancer 2:420–430 MacEwan DJ (2002) TNF receptor subtype signalling: differences and cellular consequences. Cell Signalling 14:477–492 Grell M, Wajant H, Zimmermann G et al (1998) The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor. Proc Natl Acad Sci USA 95:570–575 Grell M, Douni E, Wajant H et al (1995) The transmembrane form of tumor-necrosis-factor is the prime activating ligand of the 80 kDa tumor-necrosis-factor receptor. Cell 83:793–802 Lewis M, Tartaglia LA, Lee A et al (1991) Cloning and expression of cDNAs for 2 distinct murine tumor-necrosis-factor receptors demonstrate one receptor is species-specific. Proc Natl Acad Sci USA 88:2830–2834 Shishodia S, Aggarwal BB (2002) Nuclear factor-κB activation: a question of life or death. J Biochem Mol Biol 35:28–40 Muppidi JR, Tschopp J Siegel RM (2004) Life and death decisions: secondary complexes and lipid rafts in TNF receptor family signal transduction. Immunity 21:461–465 Millar RP, Lu ZL, Pawson AJ et al (2004) Gonadotropin-releasing hormone receptors. Endocr Rev 25:235–275 Fink G (1995) The self-priming effect of LHRH: a unique servomechanism and possible cellular model for memory. Front Neuroendocrinol 16:183–190 Anderson L (1996) Intracellular mechanisms triggering gonadotrophin secretion. Rev Reprod 1:193–202 Mitchell R, McCulloch D, Lutz E et al (1998) Rhodopsin-family receptors associate with small G proteins to activate phospholipase D. Nature 392:411–414 Kalra PS, Edwards TG, Xu B et al (1998) The anti-gonadotropic effects of cytokines: the role of neuropeptides. Domest Anim Endocrinol 15:321–332 Russell SH, Small CJ, Stanley SA et al (2001) The in vitro role of tumour necrosis factor-α and interleukin-6 in the hypothalamic-pituitary gonadal axis. J Neuroendocrinol 13:296–301 Leung PC Steele GL (1992) Intracellular signaling in the gonads. Endocr Rev 13:476–498 Escobar-Morreale HF, Calvo RM, Sancho J et al (2001) TNF-α and hyperandrogenism: a clinical, biochemical, and molecular genetic study. J Clin Endocrinol Metab 86:3761–3767 Sinaii N, Cleary SD, Ballweg ML et al (2002) High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis: a survey analysis. Hum Reprod 17:2715–2724 Sakamoto Y, Harada T, Horie S et al (2003) Tumor necrosis factor-α-induced interleukin-8 (IL-8) expression in endometriotic stromal cells, probably through nuclear factor-κB activation: gonadotropin-releasing hormone agonist treatment reduced IL-8 expression. J Clin Endocrinol Metab 88:730–735 Nothnick WB (2004 ) Novel targets for the treatment of endometriosis. Expert Opin Ther Targets 8:459–471 Author information Authors and Affiliations Corresponding author Additional information Special issue article in honor of George Fink. Rights and permissions About this article Cite this article MacEwan, D.J. Interactions between TNF and GnRH. Neurochem Res 33, 678–682 (2008). https://doi.org/10.1007/s11064-007-9505-8 Accepted: Published: Issue date: DOI: https://doi.org/10.1007/s11064-007-9505-8